|
Symbol Name ID |
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1 MGI:88587 |
| * | Aspects of the system are reported to show a normal phenotype. |
| Darker colors indicate more annotations |
| Human Phenotypes | Abnormality of metabolism/homeostasis |
| Disease(s) Associated with CYP19A1 | |
| polycystic ovary syndrome |
| Mouse Phenotypes | homeostasis/metabolism phenotype |
increased blood urea nitrogen level |
increased fasting circulating glucose level |
increased circulating glucose level |
increased circulating dihydrotestosterone level |
increased circulating testosterone level |
decreased circulating estradiol level |
increased circulating follicle stimulating hormone level |
increased circulating luteinizing hormone level |
increased circulating prolactin level |
increased circulating insulin level |
increased circulating leptin level |
increased circulating HDL cholesterol level |
increased circulating cholesterol level |
increased circulating triglyceride level |
decreased circulating alkaline phosphatase level |
increased circulating serum albumin level |
abnormal enzyme/coenzyme level |
abnormal glucose homeostasis |
impaired glucose tolerance |
insulin resistance |
abnormal lipid homeostasis |
increased urine protein level |
|
| Availability | Mouse Genotype | |||||||||||||||||||||||
| Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu | ||||||||||||||||||||||||
| Cyp19a1tm1Esi/Cyp19a1tm1Esi | ||||||||||||||||||||||||
| Cyp19a1tm1Toda/Cyp19a1tm1Toda | ||||||||||||||||||||||||
| Cyp19a1tm2.1(cre)Shah/Cyp19a1tm2.1(cre)Shah | * | |||||||||||||||||||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|
|
||
Analysis Tools